We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
-13.28%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$718B
AUM Growth
-$112B
Cap. Flow
+$11.7B
Cap. Flow %
1.63%
Top 10 Hldgs %
17.54%
Holding
7,270
New
568
Increased
2,561
Reduced
2,729
Closed
610

Sector Composition

Rank Sector Weight
1 Technology 15.03%
2 Healthcare 12.52%
3 Financials 10.5%
4 Consumer Discretionary 7.88%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOKM.WS
5851
DELISTED
Live Oak Mobility Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOKM.WS
0
EPZM
5852
DELISTED
Epizyme, Inc
EPZM
$7K ﹤0.01%
5,001
-241,909
-98% -$178K
BAK icon
5853
Braskem
BAK
$813M
$6K ﹤0.01%
455
BARK icon
5854
CALL
BARK
BARK
$96.3M
$6K ﹤0.01%
235
CSQ icon
5855
Calamos Strategic Total Return Fund
CSQ
$3.35B
$6K ﹤0.01%
+425
New +$6.33K
EDU icon
5856
New Oriental
EDU
$8.49B
$6K ﹤0.01%
299
-317,943
-100% -$4.36M
HBIO icon
5857
Harvard Bioscience
HBIO
$27.8M
$6K ﹤0.01%
163
-2,151
-93% -$97.1K
HYPR icon
5858
Hyperfine
HYPR
$95.5M
$6K ﹤0.01%
2,581
IMA
5859
ImageneBio Inc
IMA
$68M
$6K ﹤0.01%
115
-1,316
-92% -$72.6K
IMRX icon
5860
Immuneering
IMRX
$328M
$6K ﹤0.01%
1,133
-10,836
-91% -$57.8K
MNKD icon
5861
CALL
MannKind Corp
MNKD
$1.24B
$6K ﹤0.01%
1,600
MRAM icon
5862
Everspin Technologies
MRAM
$415M
$6K ﹤0.01%
1,147
-25,566
-96% -$165K
IMDX
5863
Insight Molecular Diagnostics
IMDX
$147M
$6K ﹤0.01%
318
-1,678
-84% -$38.2K
PBYI icon
5864
Puma Biotechnology
PBYI
$459M
$6K ﹤0.01%
2,232
-140,649
-98% -$350K
RODM icon
5865
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.65B
$6K ﹤0.01%
+249
New +$6.79K
SMMT icon
5866
Summit Therapeutics
SMMT
$12B
$6K ﹤0.01%
5,135
-18,849
-79% -$26.4K
SND icon
5867
Smart Sand
SND
$213M
$6K ﹤0.01%
3,143
-1,207
-28% -$4.17K
SPBC icon
5868
Simplify US Equity PLUS GBTC ETF
SPBC
$43M
$6K ﹤0.01%
300
SPRY icon
5869
ARS Pharmaceuticals
SPRY
$601M
$6K ﹤0.01%
1,497
-12,261
-89% -$42.8K
TMFC icon
5870
Motley Fool 100 Index ETF
TMFC
$2.11B
$6K ﹤0.01%
200
WIMI
5871
WiMi Hologram Cloud
WIMI
$23.9M
$6K ﹤0.01%
+279
New +$5.81K
WNEB icon
5872
Western New England Bancorp
WNEB
$282M
$6K ﹤0.01%
835
-146
-15% -$1.22K
VIRX
5873
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$6K ﹤0.01%
1,529
-19,912
-93% -$56.7K
NVACW
5874
DELISTED
NorthView Acquisition Corporation Warrant
NVACW
0
IBDP
5875
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$6K ﹤0.01%
245
-19,341
-99% -$481K

Similar funds

JP Morgan Chase's Q2 2022 Portfolio in Review

As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
  • JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
  • JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
  • JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
  • JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
  • JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.

Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.